dc.contributor.author |
Jackson, Brandon Spencer
|
|
dc.date.accessioned |
2023-12-06T05:12:35Z |
|
dc.date.available |
2023-12-06T05:12:35Z |
|
dc.date.issued |
2023-03 |
|
dc.description.abstract |
The size of adrenal incidentalomas has important implications for diagnosis and management.
Recommendations from endocrine societies do not all correlate with regard
to adrenal incidentaloma size. Therefore, the aim was to compare adrenal incidentaloma
size recommendations between different endocrine societies and the reasoning
for these recommendations.
Eight different international guidelines were reviewed and compared. The smaller the
size of the incidentaloma, the lower the risk for malignancy. The majority of guidelines
consider 4 cm as the cut-off, but there are discrepancies. Size indications for laparoscopic
adrenalectomy have a wide range from less than 4 cm up to 12 cm. The followup
period of adrenal incidentalomas, as well as what is considered significant growth
over that period, varies between the recommendations.
Therefore, the clinician should be aware of the differences when managing a patient
with adrenal incidentaloma. There are discrepancies in size considerations with regard
to significance, treatment options, optimal follow-up period, and further management. |
en_US |
dc.description.department |
Surgery |
en_US |
dc.description.librarian |
am2023 |
en_US |
dc.description.sdg |
SDG-03:Good heatlh and well-being |
en_US |
dc.description.uri |
https://urologyresearchandpractice.org/EN |
en_US |
dc.identifier.citation |
Jackson, B.S. 2023, 'Adrenal incidentaloma controversial size recommendations', Urology Research and Practice, vol. 49, no. 2, pp. 96-99, doi : 10.5152/tud.2023.22245. |
en_US |
dc.identifier.issn |
1300-5804 |
|
dc.identifier.other |
10.5152/tud.2023.22245 |
|
dc.identifier.uri |
http://hdl.handle.net/2263/93757 |
|
dc.language.iso |
en |
en_US |
dc.publisher |
AVES |
en_US |
dc.rights |
© Author(s). Article is licensed under a Creative Commons Attribution 4.0 International License. |
en_US |
dc.subject |
Adrenal incidentaloma |
en_US |
dc.subject |
Size |
en_US |
dc.subject |
Management |
en_US |
dc.subject |
Follow-up |
en_US |
dc.subject |
SDG-03: Good health and well-being |
en_US |
dc.title |
Adrenal incidentaloma controversial size recommendations |
en_US |
dc.type |
Article |
en_US |